Literature DB >> 9460061

Changes in the ageing brain in health and disease.

B H Anderton1.   

Abstract

The brains of individuals, who are cognitively normal, show age-related changes that include an overall reduction in brain volume and weight, which are associated with gyral atrophy and widening of the sulci of the cerebral cortex, and enlargement of the brain ventricles. These changes are partly the result of nerve cell loss but accurate estimates of neuronal loss are notoriously difficult to make. Microscopically, there are increasing amounts of the age-related pigment, lipofuscin, granulovacuolar degeneration in neurones, Hirano bodies, variable amounts of diffuse deposits of beta-amyloid in the parenchyma, the presence of neurofibrillary tangles mainly confined to the hippocampus and amygdala, and sparse numbers of senile plaques in these brain regions and also in other cortical areas. Of these changes, neurofibrillary tangles and senile plaques are the neuropathological hallmark of Alzheimer's disease in which they are more abundant and widespread. Alzheimer's disease has therefore been regarded as accelerated brain ageing; however, the realization that there is a strong genetic contribution to developing the disease at least implies that it may not be the inevitable, even if frequent, consequence of old age. Understanding the molecular basis of plaque and tangle formation is advancing greatly and is the main focus of research into the cellular and molecular changes observed in the ageing brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9460061      PMCID: PMC1692130          DOI: 10.1098/rstb.1997.0162

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  89 in total

1.  Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.

Authors:  R A Shiurba; K Ishiguro; M Takahashi; K Sato; E T Spooner; M Mercken; R Yoshida; T R Wheelock; H Yanagawa; K Imahori; R A Nixon
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

2.  Fibroblasts of patients affected by Down's syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation.

Authors:  S Govoni; S Bergamaschi; L Gasparini; C Quaglia; M Racchi; E Cattaneo; G Binetti; A Bianchetti; F Giovetti; F Battaini; M Trabuechi
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

3.  Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.

Authors:  K Duff; C Eckman; C Zehr; X Yu; C M Prada; J Perez-tur; M Hutton; L Buee; Y Harigaya; D Yager; D Morgan; M N Gordon; L Holcomb; L Refolo; B Zenk; J Hardy; S Younkin
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C.

Authors:  D Cook; M J Fry; K Hughes; R Sumathipala; J R Woodgett; T C Dale
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

5.  Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.

Authors:  K Furukawa; B L Sopher; R E Rydel; J G Begley; D G Pham; G M Martin; M Fox; M P Mattson
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

6.  Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities.

Authors:  M Citron; T S Diehl; G Gordon; A L Biere; P Seubert; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

7.  Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

Authors:  D R Borchelt; G Thinakaran; C B Eckman; M K Lee; F Davenport; T Ratovitsky; C M Prada; G Kim; S Seekins; D Yager; H H Slunt; R Wang; M Seeger; A I Levey; S E Gandy; N G Copeland; N A Jenkins; D L Price; S G Younkin; S S Sisodia
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

8.  Protein topology of presenilin 1.

Authors:  A Doan; G Thinakaran; D R Borchelt; H H Slunt; T Ratovitsky; M Podlisny; D J Selkoe; M Seeger; S E Gandy; D L Price; S S Sisodia
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

Review 9.  Structural basis of dementia in neurodegenerative disorders.

Authors:  K A Jellinger
Journal:  J Neural Transm Suppl       Date:  1996

10.  Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

Authors:  M Goedert; R Jakes; M G Spillantini; M Hasegawa; M J Smith; R A Crowther
Journal:  Nature       Date:  1996-10-10       Impact factor: 49.962

View more
  19 in total

Review 1.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Aging of brain: role of estrogen.

Authors:  M K Thakur; P K Sharma
Journal:  Neurochem Res       Date:  2006-10-24       Impact factor: 3.996

3.  Longitudinal pattern of regional brain volume change differentiates normal aging from MCI.

Authors:  I Driscoll; C Davatzikos; Y An; X Wu; D Shen; M Kraut; S M Resnick
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

Review 4.  Nutritional strategies to optimise cognitive function in the aging brain.

Authors:  Devin Wahl; Victoria C Cogger; Samantha M Solon-Biet; Rosilene V R Waern; Rahul Gokarn; Tamara Pulpitel; Rafael de Cabo; Mark P Mattson; David Raubenheimer; Stephen J Simpson; David G Le Couteur
Journal:  Ageing Res Rev       Date:  2016-06-26       Impact factor: 10.895

Review 5.  Age-related changes in vagal afferents innervating the gastrointestinal tract.

Authors:  Robert J Phillips; Gary C Walter; Terry L Powley
Journal:  Auton Neurosci       Date:  2009-08-07       Impact factor: 3.145

6.  Regional specificity of sex effects on subcortical volumes across the lifespan in healthy aging.

Authors:  Wenjing Li; Marie-José van Tol; Meng Li; Wen Miao; Yonghong Jiao; Hans-Jochen Heinze; Bernhard Bogerts; Huiguang He; Martin Walter
Journal:  Hum Brain Mapp       Date:  2012-09-21       Impact factor: 5.038

Review 7.  Myths and truths about the cellular composition of the human brain: A review of influential concepts.

Authors:  Christopher S von Bartheld
Journal:  J Chem Neuroanat       Date:  2017-09-02       Impact factor: 3.052

Review 8.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

9.  Long-term treatment of l-3-n-butylphthalide attenuated neurodegenerative changes in aged rats.

Authors:  Shiping Ma; Shaofeng Xu; Bin Liu; Jiang Li; Nan Feng; Ling Wang; Xiaoliang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-12       Impact factor: 3.000

10.  GIN'n'CIN hypothesis of brain aging: deciphering the role of somatic genetic instabilities and neural aneuploidy during ontogeny.

Authors:  Yuri B Yurov; Svetlana G Vorsanova; Ivan Y Iourov
Journal:  Mol Cytogenet       Date:  2009-11-25       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.